Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D3TX
|
||||
Former ID |
DNCL001975
|
||||
Drug Name |
EVP-6124
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Mild to moderate alzheimer disease; Schizophrenia [ICD9: 331, 295; ICD10:G30, F20] | Phase 3 | [524557] | ||
Company |
EnVivo Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H17ClN2OS
|
||||
Canonical SMILES |
C1CN2CCC1C(C2)NC(=O)C3=CC4=C(S3)C(=CC=C4)Cl
|
||||
InChI |
1S/C16H17ClN2OS/c17-12-3-1-2-11-8-14(21-15(11)12)16(20)18-13-9-19-6-4-10(13)5-7-19/h1-3,8,10,13H,4-7,9H2,(H,18,20)/t13-/m0/s1
|
||||
InChIKey |
SSRDSYXGYPJKRR-ZDUSSCGKSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuronal acetylcholine receptor protein, alpha-7 chain | Target Info | Modulator | [532624] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.